Employees Retirement System of Texas’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,508
Closed -$244K 818
2021
Q3
$244K Hold
5,508
﹤0.01% 766
2021
Q2
$313K Hold
5,508
﹤0.01% 723
2021
Q1
$412K Hold
5,508
0.01% 714
2020
Q4
$476K Hold
5,508
0.01% 621
2020
Q3
$337K Hold
5,508
﹤0.01% 689
2020
Q2
$229K Hold
5,508
﹤0.01% 716
2020
Q1
$158K Hold
5,508
﹤0.01% 735
2019
Q4
$398K Hold
5,508
0.01% 763
2019
Q3
$773K Buy
+5,508
New +$921K 0.01% 764

Other funds holding SAGE

Employees Retirement System of Texas's SAGE Position: Q4 2021 in Review

Employees Retirement System of Texas sold out of Sage Therapeutics (SAGE) in Q4 2021, closing a stake of 5,508 shares — an estimated $244K sold.

Employees Retirement System of Texas first reported a position in SAGE in Q3 2019 and held it in 9 quarters. The position peaked at $773K in Q3 2019. 217 funds tracked by Wall St. Rank hold SAGE as of Q4 2021.

  • Employees Retirement System of Texas reported no remaining Sage Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Employees Retirement System of Texas sold 5,508 Sage Therapeutics shares in Q4 2021, an estimated $244K.
  • Employees Retirement System of Texas first reported a position in Sage Therapeutics in Q3 2019 and held it in 9 quarters.
  • Employees Retirement System of Texas's Sage Therapeutics position peaked at $773K in Q3 2019.
  • 217 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2021.

Based on Employees Retirement System of Texas's 13F filing for Q4 2021, filed 15 Feb 2022.